Xofluza 20 mg, Filmtabletten
7680674260011
CH-67426
Filmtabletten
Associated product:
Xofluza 20 mg, Filmtabletten
1 / 3
google
Article details
- Package size
- 2
- Selling units
- 2
- Measure
- Tablette(n)
- Galenic form
- Filmtabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
baloxavirum marboxilum
|
20.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
77.9 MG | Substance | HBESI |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
povidonum K 25
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
natrii stearylis fumaras
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
natrium
|
1.13 MG | Substance | HBESI |
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 67426
- Drug name
- Xofluza, Filmtabletten
- Galenic form
- FILM
- ATC Code
- J05AX25
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 19/02/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- XOFLUZA cpr pel 20 mg 2 pce
- Description (DE)
- XOFLUZA Filmtabl 20 mg 2 Stk
- Market launch
- 19/02/2020
- Market withdrawal
- 31/12/2022
- Narcotic (BTM)
- No